CLDX - Celldex TherapeuticsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $44.33 | Open | $44.18 |
| Volume | 837.3K | Market Cap | 2.06B |
| Yield | Last Dividend |
| Oral Live Cholera Vaccines Market Size, ... | 4:25 PM |
| The documented report on Global Oral Live Cholera Vaccines Market by Reports Globe aims to offer an organized and methodical strategy for important as... | |
| Immunotoxins Market 2021 SWOT Analysis, ... | 9:19 AM |
| This report studies the Immunotoxins Market with many aspects of the industry such as market size, market status, market trends and forecast. The repo... | |
| Anaplastic Oligoastrocytoma Drug Market ... | 2:47 AM |
| This report studies the Anaplastic Oligoastrocytoma Drug Market with many aspects of the industry such as market size, market status, market trends an... | |
| Cholera Vaccines Market 2021 SWOT Analys... | 07/24/21 |
| This report studies the Cholera Vaccines Market with many aspects of the industry such as market size, market status, market trends and forecast. The ... | |
| Global Cholera Vaccine Market 2021 Futur... | 07/23/21 |
| The report on Global Cholera Vaccine Market has been provided by researchers for a detailed understanding of market performance over an estimated peri... | |
| Celldex rises with bullish call from Gug... | 07/22/21 |
| No summary available. | |
| Celldex Therapeutics Inc. Shares Close t... | 07/17/21 |
| Celldex Therapeutics Inc. (CLDX) shares closed this week 41.3% higher than it did at the end of last week. The stock is currently up 150.3% year-to-d... | |
| Celldex Therapeutics Announces Closing o... | 07/16/21 |
| HAMPTON, N.J., July 16, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Celldex or the Company) (Nasdaq: CLDX) today announced the closing of its... | |
| The Daily Biotech Pulse: Galapagos Sinks... | 07/15/21 |
| Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Al... | |
| Analysts Recommendations to Consider: Ce... | 07/14/21 |
| Celldex Therapeutics, Inc. (CLDX) with the stream of -0.72% also noticed, India Professional Diversity Network, Inc. (IPDN) encountered a rapid change... | |
| The Daily Biotech Pulse: ScPharma''s Pos... | 07/14/21 |
| Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Bi... | |
| Celldex Therapeutics Raises $250M Via Eq... | 07/14/21 |
| Celldex Therapeutics Inc (NASDAQ: CLDX ) has priced an underwritten public offering of around 5.9 million shares at $42. | |
| Celldex Therapeutics Raises $250M Via Eq... | 07/14/21 |
| Celldex Therapeutics Inc (NASDAQ: CLDX ) has priced an underwritten public offering of around 5.9 million shares at $42.00 per share , representing a ... | |
| Celldex Therapeutics raises $250M via eq... | 07/13/21 |
| No summary available. | |
| Celldex Therapeutics Inc. Shares Near 52... | 07/13/21 |
| Celldex Therapeutics Inc. (CLDX) shares closed today at 1.7% below its 52 week high of $45.39, giving the company a market cap of $1B. The stock is c... | |
| Celldex''s Latest Data For Chronic Induc... | 07/13/21 |
| No summary available. | |
| The Buzz Show: Celldex Therapeutics, Inc... | 07/12/21 |
| FinancialBuzz.coms latest The Buzz Show: Featuring Our Corporate News Recap on Celldex Therapeutics, Inc. Shares Surge After Positive Trial Data Celld... | |
| Celldex Therapeutics proposes $175M capi... | 07/12/21 |
| No summary available. | |
| Celldex Therapeutics Announces Proposed ... | 07/12/21 |
| HAMPTON, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Celldex or the Company) (Nasdaq: CLDX) today announced that it is proposi... | |
| Where Do Hedge Funds Stand On Celldex Th... | 07/12/21 |
| No summary available. | |
| Mid-day market update: Crude oil down 1%... | 07/12/21 |
| Midway through trading Monday, the Dow traded up 0.28% to 34,967.12 while the NASDAQ rose 0.08% to 14,714.09. The S&P also rose, gaining 0.23% to 4,37 | |
| Mid-Day Market Update: Crude Oil Down 1%... | 07/12/21 |
| Midway through trading Monday, the Dow traded up 0.28% to 34,967.12 while the NASDAQ rose 0.08% to 14,714.09. The S&P also rose, gaining 0.23% to 4,37... | |
| Why Celldex Therapeutics Stock Is Skyroc... | 07/12/21 |
| Investors liked Celldex''s early stage clinical results. | |
| Thinking about trading options or stock ... | 07/12/21 |
| NEW YORK , July 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLDX, TSLA, PRTA, MSFT, and ANVS. Full story availabl... | |
| Animal health ratings change at Guggenhe... | 07/12/21 |
| No summary available. | |
| Celldex gains over a third on early-stag... | 07/10/21 |
| No summary available. | |
| Celldex Therapeutics Presents Positive D... | 07/09/21 |
| - 95% complete response rate after single dose of CDX-0159 - - Rapid, profound and durable responses offer patients opportunity for quick, lasting, me... | |
| Celldex: Powerful Medicines To Yield Fur... | 07/08/21 |
| No summary available. | |
| A Study of CDX-0159 in Patients With Pru... | 06/30/21 |
| Condition : Prurigo Nodularis Interventions : Biological: CDX-0159; Drug: Normal saline Sponsor : Celldex Therapeutics Not yet recruiting | |
| Follicular Lymphoma Treatment Market 202... | 06/23/21 |
| The report titled Follicular Lymphoma Treatment Market has recently added by MarketInsightsReports to get a stronger and effective business outlook. I... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 67.00 % | Follow |
| LavaPit | Steve Pitkin | 57.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
